HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clarins earnings

This article was originally published in The Rose Sheet

Executive Summary

Strong launch schedule, including introduction of ClarinsMen skin care and Hugo Boss Boss In Motion fragrance in second half of the year, expected to improve French firm's financial performance by year end, Clarins says. Consolidated sales in first six months were up 2.8% to $426.1 mil. (1"The Rose Sheet" Aug. 13, 2001, In Brief). However, operating profit plunged 41.2% to $28.5 mil. (€1=$.97) and net profit dropped 22.9% to $18.7 mil., company announces in a 2first-half earnings report Sept. 12. Operating profit declines were attributed to losses recorded by Thierry Mugler couture and perfume distribution, rising production costs and selling expenses and weak sales of the Clarins brand in May and June...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010594

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel